Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × INDUSTRY × Hemangiosarcoma × Clear all

Phase

Phase 2 4 Phase 1 4 Phase 1/2 2 Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

NETWORK 5 OTHER 3 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 358 Breast Neoplasms 321 Neoplasms 244 Prostatic Neoplasms 169 Neoplasm Metastasis 134 Multiple Myeloma 119 Colorectal Neoplasms 102 Ovarian Neoplasms 88 Lung Neoplasms 86 Parkinson Disease 4, Autosomal Dominant Lewy Body 83 Lymphoma, Follicular 80 Recurrence 74 Melanoma 74 Carcinoma, Hepatocellular 73 Lymphoma, Non-Hodgkin 71 Papillomavirus Infections 69 Leukemia, Lymphocytic, Chronic, B-Cell 67 Small Cell Lung Carcinoma 63 Leukemia, Myeloid, Acute 63 Stomach Neoplasms 60 Carcinoma, Renal Cell 58 Pain 57 Keratosis, Actinic 56 Uterine Cervical Neoplasms 54 Pancreatic Neoplasms 54 Urinary Bladder Neoplasms 49 Lymphoma, Large B-Cell, Diffuse 46 Myasthenia Gravis 44 Carcinoma 43 Leiomyoma 40

Interventions

pazopanib 1 carotuximab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02979899 2020-05-12

TAPPAS

Tracon Pharmaceuticals Inc.

Phase 3 Completed

128 enrolled 13 charts

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡